Safety Department Readiness for Expedited SAE Reports
Safety Department Readiness for Expedited SAE Reports Preparing Safety Departments for Expedited SAE Reporting in Clinical Trials Why Safety Department Readiness Is Essential The safety department, often referred to as the pharmacovigilance (PV) unit, plays a pivotal role in ensuring that Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) are reported within…
Read More “Safety Department Readiness for Expedited SAE Reports” »